Jeffrey Drebin

Title: **Innovator Profile: Jeffrey Drebin of Bryn Mawr, PA**

Introduction

Jeffrey Drebin, an esteemed inventor based in Bryn Mawr, Pennsylvania, has made significant contributions in the field of medical innovation. With a focus on enhancing cancer treatments, his work continues to impact the lives of many patients facing this formidable disease.

Latest Patents

Drebin holds a patent titled "Methods of increasing response to cancer radiation therapy." This groundbreaking patent details methods designed to improve the effectiveness of radiation therapy in cancer-afflicted subjects. Notably, the methods involve reducing the ability of immune suppressor cells (such as MDSC) to migrate to the cancer microenvironment. Additionally, the patent outlines techniques for suppressing the migration of these immune suppressor cells to non-malignant cells and preventing the malignant transformation of those cells.

Career Highlights

Currently, Jeffrey Drebin is associated with the University of Pennsylvania, where he contributes to cutting-edge research in cancer therapy. His dedication to advancing medical science is evident in his single yet impactful patent, which showcases his commitment to combating cancer more effectively.

Collaborations

Throughout his career, Drebin has collaborated with notable colleagues, including Mark I. Greene and Hongtao Zhang. These partnerships not only enhance his research endeavors but also foster a collaborative environment that encourages further innovations in the realm of cancer treatment.

Conclusion

In summary, Jeffrey Drebin stands out as a pivotal figure in the field of cancer research and innovation. His patent demonstrates a profound understanding of cancer dynamics and the immune response, providing hope for enhanced therapeutic strategies. As he continues his work at the University of Pennsylvania, the impact of his contributions will likely resonate within the medical community and beyond.